Transient hyphema associated with PRESERFLO® MicroShunt surgery using a double-step knife in patients with glaucoma

Rei Sakata1,2,3, Makoto Aihara4,5, Shiroaki Shirato5

  • 1Department of Ophthalmology, Graduate of Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. reisakata-tky@umin.ac.jp.

Scientific Reports
|November 18, 2024
PubMed

Insights

Hyphema, or bleeding in the eye, occurred in 35% of patients after PRESERFLO® MicroShunt (PMS) surgery. This complication was frequent regardless of the precise tube insertion site, indicating a notable risk for patients.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Glaucoma Management

Background:

  • Glaucoma is a leading cause of irreversible blindness worldwide.
  • The PRESERFLO® MicroShunt (PMS) surgery is a surgical option for managing glaucoma.
  • Understanding potential complications like hyphema is crucial for patient counseling and surgical technique refinement.

Purpose of the Study:

  • To determine the frequency of hyphema following PRESERFLO® MicroShunt (PMS) surgery.
  • To explore the relationship between hyphema occurrence and the specific tube insertion position.
  • To analyze the impact of hyphema on visual acuity and intraocular pressure post-surgery.

Main Methods:

  • Retrospective review of glaucoma patients who underwent PMS surgery using a double-step knife.
  • Definition of hyphema as visible hemorrhage in the anterior chamber.
  • Gonioscopic confirmation of PMS tube insertion position and comparison between hyphema and non-hyphema groups.

Main Results:

  • Hyphema occurred in 23 out of 65 (35%) eligible eyes.
  • No significant difference in tube insertion site was found between patients with and without hyphema.
  • All hyphema cases resolved spontaneously within weeks, with stable intraocular pressure and recovered visual acuity.

Conclusions:

  • Hyphema is a frequent complication of PRESERFLO® MicroShunt surgery performed with a double-step knife.
  • The occurrence of hyphema appears independent of the accuracy of the tube insertion site.
  • Patients should be counseled on the risk of hyphema prior to undergoing PMS surgery.